AGORACOM Small Cap 60: Why is Awakn Targeting The UK and EU

Biotech Company With Clinical Operations Developing Psychedelic Medicine To Treat Addiction

First 3 UK Clinics Opened In 2021, Targeting 20 Clinics By 2024 ~$100M In Revenue

Reply New Message

Prev Message Back To Forum Threaded View Next Message

agoracom administrator

Rank: Administrator [?]

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

AGORACOM Small Cap 60: Why is Awakn Targeting The UK and EU

posted on Nov 11, 2021 10:30AM

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply